1,049 coding-"https:"-"FEMTO-ST"-"CSIC" "https:" "https:" "https:" "UCL" "UCL" positions at Duke University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
research can be found here: https://globalhealth.duke.edu/center-global-mental-health Beyond the engaging work, you'll also benefit from Duke's competitive benefits package including health insurance plans
-
biology, and evolution. Learn more about our interests, motivations and discoveries: https://sites.duke.edu/silverlab/ . Conduct independent research activities under the guidance of a faculty mentor in
-
discover how we can advance health together. Duke Health Integrated Practice https://careers.dukehealth.org/us/en/dhip Duke Health Integrated Practice comprises more than 110 primary and specialty outpatient
-
. Learn more at: https://hr.duke.edu/benefits/ Equal Opportunity Employer: Duke is an Equal Opportunity Employer committed to providing employment opportunity without regard to an individual's age, color
-
competitive medical and dental care programs, generous retirement benefits, and a wide array of family-friendly and cultural programs to eligible team members. Learn more at: https://hr.duke.edu/benefits
-
academic integrity processes and ADA academic accommodation services with a strategic, data‑informed, and student‑centered approach. What You'll Do: - Lead the end‑to‑end administration of the Honor Code
-
, minorities, individuals with disabilities, and veterans. Application Materials Required: Further Info: http://aahvs.duke.edu/ (919) 684-3060 114 S. Buchanan Blvd. Duke University Box 90766 Durham, NC 27708
-
to recruit, hire, and promote qualified women, minorities, individuals with disabilities, and veterans. Application Materials Required: Further Info: http://aahvs.duke.edu/ (919) 684-3060 114 S. Buchanan Blvd
-
discover how we can advance health together. Duke Health Integrated Practice https://careers.dukehealth.org/us/en/dhip Duke Health Integrated Practice comprises more than 110 primary and specialty outpatient
-
, and have a mandate by the NIH to inform new therapies for this difficult-to-treat disease. Focus is on understanding how corrupt coding and non-coding (“dark genome”) genes that are part of